Azetro Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 72.56%
- Profit Growth -23.63%
- Ebitda -23.96%
- Net Worth 11.70%
- Total Assets 21.74%
About Azetro Pharmaceuticals
Azetro Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 February 2015 (Nine years and 11 months 14 days old ). Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vineet Singh and Prem Chaurasia serve as directors at the Company.
Company Details
-
Location
Varanasi, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33111UP2015PTC069212
-
Company No.
069212
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Feb 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Azetro Pharmaceuticals Private Limited offer?
Azetro Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Juices, Soups & Soft Drinks, Beverages Mixes, Protein Powder, Common Disease Medicines, Pharmaceutical Medicine, Digestive System Drugs & Medicines, Digestive Drugs.
Who are the key members and board of directors at Azetro Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Chaurasia
|
Director | 26-Feb-2015 | Current |
|
Vineet Singh
|
Director | 26-Feb-2015 | Current |
Financial Performance of Azetro Pharmaceuticals.
Azetro Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 72.56% increase. The company also saw a substantial fall in profitability, with a 23.63% decrease in profit. The company's net worth Soared by an impressive increase of 11.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azetro Pharmaceuticals?
In 2017, Azetro Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Azetro Pharmaceuticals?
Unlock and access historical data on people associated with Azetro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azetro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azetro Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.